HHS plopped down another $628 million to make coronavirus vaccine candidates at a facility built in part with government funding under the Obama administration, adding to the list of contracts for products to be made at the public-private facilities. Government manufacturing of coronavirus vaccines and drugs would give the government more power over price and would secure supplies for Americans amid fierce global competition for those products. The $628 million goes to Emergent BioSolutions as part of the Trump administration’s...